Vaximm starts trial of oral pancreatic cancer vaccine; Hospital fined for improper vaccine storage;

> Merck KGaA spin-off VAXIMM has kicked off its first clinical trial of oral pancreatic cancer vaccine VXM01. Release

> Soligenix has started development of a next generation anthrax vaccine as part of an agreement with Harvard University. Release

> The Daily Beast explores in a lengthy article asking whether cancer vaccines could be the key to defeating the disease. Article

> GeoVax Labs' gas inoculated the first patient in a Phase I/II trial of the company's therapeutic HIV/AIDS vaccine. GeoVax release

And Finally... South San Francisco's Kaiser Foundation Hospital was fined $50,000 for storing vaccines with a "do not freeze" warning in sub-freezing temperatures for up to 32 months. Report

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.